Rethinking the Role of Clinical Trial Data in International Intellectual Property Law: The Case for a Public Goods Approach
Publication
, Journal Article
Reichman, J
Published in: Marquette Intellectual Property Law Review
2009
Duke Scholars
Published In
Marquette Intellectual Property Law Review
Publication Date
2009
Volume
13
Start / End Page
1 / 68
Related Subject Headings
- 4806 Private law and civil obligations
- 4803 International and comparative law
- 4801 Commercial law
- 1801 Law
Citation
APA
Chicago
ICMJE
MLA
NLM
Reichman, J. (2009). Rethinking the Role of Clinical Trial Data in International Intellectual Property Law: The Case for a Public Goods Approach. Marquette Intellectual Property Law Review, 13, 1–68.
Reichman, J. “Rethinking the Role of Clinical Trial Data in International Intellectual Property Law: The Case for a Public Goods Approach.” Marquette Intellectual Property Law Review 13 (2009): 1–68.
Reichman J. Rethinking the Role of Clinical Trial Data in International Intellectual Property Law: The Case for a Public Goods Approach. Marquette Intellectual Property Law Review. 2009;13:1–68.
Reichman, J. “Rethinking the Role of Clinical Trial Data in International Intellectual Property Law: The Case for a Public Goods Approach.” Marquette Intellectual Property Law Review, vol. 13, 2009, pp. 1–68.
Reichman J. Rethinking the Role of Clinical Trial Data in International Intellectual Property Law: The Case for a Public Goods Approach. Marquette Intellectual Property Law Review. 2009;13:1–68.
Published In
Marquette Intellectual Property Law Review
Publication Date
2009
Volume
13
Start / End Page
1 / 68
Related Subject Headings
- 4806 Private law and civil obligations
- 4803 International and comparative law
- 4801 Commercial law
- 1801 Law